Top
Links

Publications

  • Loewen P, Dahri K. Risk of bleeding with oral anticoagulants: An updated systematic review and performance analysis of clinical prediction rules. Annals of Hematology [in press].
  • Bruchet N, de Lemos J, Loewen P. Improving the quality of clinical pharmacy services:  a process to identify and capture high value “Quality Actions” . Can J Hosp Pharm 2011;64:42-7.
  • Schwenger EM, Tejani AM, Loewen PS. Probiotics for preventing urinary tract infections in adults and children. Cochrane Database of Systematic Reviews 2010, Issue 10. Art. No.: CD008772. DOI: 10.1002/14651858.CD008772.
  • Loewen P.  Should a process be developed to recognize "pharmacy practice residency equivalency" for pharmacists with substantial clinical experience who have not completed a pharmacy practice residency?  Can J Hosp Pharm 2010;63:30-1.
  • Barry A, Loewen P, deLemos J, Lee KG.  Reasons for non-use of proven pharmacologic interventions in hospitalised patients: A systematic review.  Journal of Evaluation In Clinical Practice. 2010; doi:10.1111/j.1365-2753.2010.01524.x (August 2010).
  • Loewen P, Merrett F, de Lemos J. Pharmacists' perceptions of the impact of care they provide. Pharm Pract 2010;8(2):89-95.
  • Mountford C, Lee T, de Lemos J, Loewen P. Quality and Usability of Common Drug Information Databases. Can J Hosp Pharm 2010;63(2):130–137.
  • Hohl CM, Zed PJ, Brubacher JR, Abu-Laban RB, Loewen PS, Purssell RA.  Do Emergency Physicians Attribute Drug-Related Emergency Department Visits to Medication-Related Problems?.  Annals of Emergency Medicine 2009; doi:10.1016/j.annemergmed.2009.10.008 [PubMed]
  • Barry A, Loewen P, de Lemos J, Lee KG.  Reasons for non-use of proven pharmacologic interventions in hospitalised patients: Pharmacists’ perspectives.  Can J Hosp Pharm 2009;62(5):381–385. 
  • Loewen P. Should the window for intravenous administration of tissue plasminogen activator in the treatment of acute ischemic stroke be extended to 4.5 hours? Can J Hosp Pharm  2009;62(3):248-51. 
  • Zed PJ, Abu-Laban R, Balen RM, Loewen PS, Hohl CM, Brubacher JR, et al.  Incidence, Severity and Preventability of Drug-Related Visits to the Emergency Department: A Prospective Study. CMAJ 2008;178(12):1563-9. [CMAJ]
  • Huang C, Loewen P, Pelletier T, Slater J, Chung M. Implementation of proven interventions in general medical inpatients. Qual Saf Health Care 2008;17:269-74. [Pubmed] 
  • Dahri K, Loewen P. The Risk of Bleeding with Warfarin: A systematic review and performance analysis of clinical prediction rules. Thrombosis & Haemostasis 2007;98:980-7. [PubMed]
  • McCormack J, Loewen P.  Adding “value” to clinical practice guidelines.  Can Fam Physician 2007;53:1326-1327.   [PubMed]
  • Patel K, Loewen P, Wilbur K. A retrospective evaluation of adherence to guidelines for prevention of thromboembolic events in general medical inpatients. Can J Hosp Pharm 2006;59:258-63.
  • Saran MK, Loewen PS, Zed PJ. Opportunities for optimizing pantoprazole therapy in patients with acute upper gastrointestinal bleeding. Hosp Pharm 2006;41:354-60. [HP]
  • Raybardhan S, Balen RM, Partovi N, Loewen P, Liu G, Jewesson PJ.  Documenting drug-related problems with personal digital assistants in a multisite health system. Am J Health-Syst Pharm 2005;62:1782-7.  [PubMed]
  • Sprague DA, Loewen PS, Raymond CB. Selection of atypical antipsychotics for the management of schizophrenia. Ann Pharmacother 2004;38:313-9. [PubMed]
  • Zed PJ, Rowe B, Loewen PS, Abu-Laban RB. Systematic reviews in emergency medicine:  Part II. Critical appraisal of review quality, data synthesis and result interpretation. Can J Emerg Med 2003;5:406-11. [PubMed]
  • Zed PJ, Rowe B, Loewen PS, Abu-Laban RB. Systematic reviews in emergency medicine:  Part I. Background and general principles for locating and critically appraising reviews. Can J Emerg Med 2003;5:331-5. [PubMed]
  • Loewen P, Lamb S, Clugston P. A randomized, double-blind, trial of dolasetron versus droperidol for prophylaxis of postoperative nausea and vomiting in patients undergoing TRAM flap breast reconstruction surgery. Ann Plast Surg 2003;51:472-7. [PubMed]
  • Loewen PS, Sprague D. Bedside calculation of stroke risk in patients with atrial fibrillation. Am J Health-Syst Pharm 2003;60:427-2. [PubMed]
  • Loewen P. Antiemetics in development. Expert Opin Investig Drugs 2002;11:801-5. [PubMed]
  • Loewen P.  Review of the selective COX-2 inhibitors celecoxib and rofecoxib: focus on clinical aspects. Can J Emerg Med 2002;4:268-75. [PubMed]
  • Loewen P, Zed P, Jewesson PJ. A response to the ACP-ASIM position statement on pharmacists scope of practice. Am J Health-Syst Pharm 2002;59:1453-7. [PubMed]
  • Zed PJ, Loewen PS, Slavik R, Marra CA.  Meta-analysis of proton pump inhibitors in treatment of bleeding peptic ulcers. Ann Pharmacother 2001;35:1528-34. [PubMed]
  • Sinclair S, Frighetto L, Loewen PS, Sunderji R, Marra CA, Teal P, Fagan S.  Cost-utility analysis of tissue plasminogen activator for acute ischemic stroke: a Canadian healthcare perspective. Pharmacoeconomics 2001;19(9):927-36. [PubMed]
  • Loewen PS, Marra CM, Zed PJ. 5-HT3 receptor antagonists versus traditional agents for the prophylaxis of postoperative nausea and vomiting:  a meta-analysis. Can J Anaesthesiol 2000;47:1008-18. [PubMed]
  • Frighetto L, Loewen P, Dolman J, Marra C. Cost-effectiveness of prophylactic dolasetron or droperidol vs. rescue therapy in the prevention of post-operative nausea and vomiting (PONV) in ambulatory gynaecology patients.  Can J Anaesthesia 1999;46(6):536-43. [PubMed]
  • Zed PJ, Loewen PS, Robinson G. Medication-induced headache: overview and systematic review of therapeutic approaches. Ann Pharmacother 1999;33:61-72. [PubMed]
  • Loewen PS, Marra CA, Marra F.  Systematic review of the treatment of early Lyme disease.  Drugs 1999;57(2):157-73. [PubMed]
  • Loewen P, Marra C, Marra F.  Influence of presentation of clinical trial data on pharmacists willingness to recommend drug therapy. Can J Hosp Pharm 1999;52(3):145-149. [PubMed]
  • Esmail ZN, Loewen PS. Losartan as an alternative to ACE inhibitors in patients with renal dysfunction.  Ann Pharmacother 1998;32:1096-8. [PubMed]
  • Loewen P, Sunderji R, Gin K. The efficacy and safety of combination warfarin and ASA therapy: a systematic review of the literature and update of guidelines.  Can J Cardiol 1998;14(5):717-26. [PubMed]
  • McCormack J, Loewen P, Jewesson P. Dissemination of results needs to be tracked as well as the funding is. [Letter]. BMJ  2005;331:456 (20 August). [PubMed]
  • McCormack J, Loewen P. The other side of the bezafibrate infarction prevention trial data [Letter]. Arch Intern Med 2005;165:2432-3. [PubMed]
  • McCormack J, Loewen P. Misplaced allegations [Letter]. CMAJ 2004;170:1207. [PubMed] 
  • Loewen P, Marra C. Internet resources of interest to pharmacists.  Brit Col Pharmacy 1997;6(2):30-33. 
  • Loewen P.  Use of E-mail for conducting surveys [Letter].  American Journal of Health-System Pharmacy.  Am J Health-Syst Pharm 1997;54(11):1334. [PubMed]